![Steven Cobourn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Cobourn
Director of Finance/CFO at
NEXTCURE, INC.
Net worth: - $ as of 30/06/2026
Profile
Steven P.
Cobourn is Chief Financial Officer at NextCure, Inc. since 2018.
Formerly, Chief Financial Officer at Vaccinex, Inc. from 2014 to 2018.
Treasurer & Vice President-Finance at Otsuka America Pharmaceutical, Inc. from 2003 to 2014.
Completed undergraduate education at Drexel University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NEXTCURE, INC. -.--% | 30/01/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Steven Cobourn active positions
| Companies | Position | Start |
|---|---|---|
| NEXTCURE, INC. | Director of Finance/CFO | 01/01/2018 |
Former positions of Steven Cobourn
| Companies | Position | End |
|---|---|---|
| VACCINEX, INC. | Director of Finance/CFO | 01/01/2018 |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Director of Finance/CFO | 01/04/2014 |
Training of Steven Cobourn
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
18
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Vaccinex, Inc.
 Vaccinex, Inc. BiotechnologyHealth Technology Discovers and develops targeted biotherapeutics | Health Technology |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
- Stock Market
- Insiders
- Steven Cobourn
Choose MarketScreener 
